These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacologically induced changes in the 3':5'-cyclic guanosine monophosphate content of rat cerebellar cortex: difference between apomorphine, haloperidol and harmaline. Biggio G; Costa E; Guidotti A J Pharmacol Exp Ther; 1977 Jan; 200(1):207-15. PubMed ID: 13199 [TBL] [Abstract][Full Text] [Related]
3. Increase in rat regional brain cyclic nucleotides by thyrotropin-releasing hormone (TRH) and its analog DN-1417. Narumi S; Nagai Y; Saji Y; Nagawa Y Jpn J Pharmacol; 1983 Oct; 33(5):915-26. PubMed ID: 6139495 [TBL] [Abstract][Full Text] [Related]
4. Involvement of glutamate and gamma-aminobutyric acid (GABA)-ergic systems in thyrotropin-releasing hormone-induced rat cerebellar cGMP formation. Nakayama T; Hashimoto T; Nagai Y Eur J Pharmacol; 1996 Dec; 316(2-3):157-64. PubMed ID: 8982682 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of climbing and mossy fiber input to mouse cerebellar Purkinje cells by cholecystokinin. Wood PL; Steel DJ; Kim HS; Petrack B; Altar CA J Pharmacol Exp Ther; 1988 Jan; 244(1):58-62. PubMed ID: 2826774 [TBL] [Abstract][Full Text] [Related]
6. [Effect of thyrotropin releasing hormone (TRH) on GABA (gamma aminobutyric acid) metabolism in mouse and rat brains: as to the activities of GAD (glutamic acid decarboxylase), GABA-T (GABA-transaminase) and GABA re-uptake]. Kurahashi K; Kaneko S; Matsunaga M; Sato T; Takebe K No To Shinkei; 1985 Dec; 37(12):1211-6. PubMed ID: 3937548 [TBL] [Abstract][Full Text] [Related]
7. Effects of thyroliberin, triiodothyronine and cyclic guanosine 3'5'-monophosphate on the volume of nuclei of thyrotropic cells in rat anterior pituitary in vitro. LewiĆski A Endokrinologie; 1978 May; 72(2):175-82. PubMed ID: 216538 [TBL] [Abstract][Full Text] [Related]
8. Effects of thyroid hormone, TRH and TSH on pro-TRH concentrations in various organs of rats. Mitsuma T; Hirooka Y; Yuasa K; Nogimori T Endocrinol Exp; 1990 Dec; 24(4):395-402. PubMed ID: 2128932 [TBL] [Abstract][Full Text] [Related]
9. Cerebellar cyclic GMP in p,p'-DDT myoclonus: effects of antimyoclonic agents. Chung E Res Commun Chem Pathol Pharmacol; 1983 Apr; 40(1):87-98. PubMed ID: 6306746 [TBL] [Abstract][Full Text] [Related]
10. Effects of general central nervous system depressants with and without calcium ionophore A23187 of rat cerebellar cyclic guanosine 3',5'-monophosphate. Dodson RA; Johnson WE Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):265-80. PubMed ID: 6251522 [TBL] [Abstract][Full Text] [Related]
11. Alterations in brain cyclic guanosine 3':5'-monophosphate levels after acute and chronic treatment with ethanol. Hunt WA; Redos JD; Dalton TK; Catravas GN J Pharmacol Exp Ther; 1977 Apr; 201(1):103-9. PubMed ID: 15100 [TBL] [Abstract][Full Text] [Related]
12. Effects of hypophysectomy on TRH and its related peptides concentrations in various rat organs. Mitsuma T; Hirooka Y; Kayama K; Tomari Y; Nogimori T Endocr Regul; 1994 Sep; 28(3):125-31. PubMed ID: 7858243 [TBL] [Abstract][Full Text] [Related]
13. On the mechanism of the decrease in cerebellar cyclic GMP content elicited by opiate receptor agonists. Biggio G; Guidotti A; Costa E Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):117-21. PubMed ID: 189228 [TBL] [Abstract][Full Text] [Related]
14. Changes of rat cerebellar guanosine 3',5'-cyclic phosphate by dopaminergic mechanisms in vivo. Burkard WP; Pieri L; Haefely W Adv Biochem Psychopharmacol; 1976; 15():315-24. PubMed ID: 192051 [TBL] [Abstract][Full Text] [Related]
15. Zolpidem, a novel nonbenzodiazepine hypnotic. II. Effects on cerebellar cyclic GMP levels and cerebral monoamines. Scatton B; Claustre Y; Dennis T; Nishikawa T J Pharmacol Exp Ther; 1986 May; 237(2):659-65. PubMed ID: 2871179 [TBL] [Abstract][Full Text] [Related]
16. Hindlimb-suspension and spaceflight both alter cGMP levels in rat choroid plexus. Carcenac C; Herbute S; Masseguin C; Mani-Ponset L; Maurel D; Briggs R; Guell A; Gabrion JB J Gravit Physiol; 1999 Oct; 6(2):17-24. PubMed ID: 11543082 [TBL] [Abstract][Full Text] [Related]
17. Development of tolerance to chronic barbital treatment in the cerebellar cyclic guanosine monophosphate system and its response to subsequent barbital abstinence. Lane SJ; Morgan WW J Pharmacol Exp Ther; 1985 Sep; 234(3):569-74. PubMed ID: 2993585 [TBL] [Abstract][Full Text] [Related]
18. Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms. Giorgi M; D'Angelo V; Esposito Z; Nuccetelli V; Sorge R; Martorana A; Stefani A; Bernardi G; Sancesario G Eur J Neurosci; 2008 Sep; 28(5):941-50. PubMed ID: 18717735 [TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone level positively regulates NOS and cGMP in the developing rat cerebellum. Serfozo Z; de Vente J; Elekes K Neuroendocrinology; 2009; 89(3):337-50. PubMed ID: 19229110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]